Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
650 Views
eMediNexus 14 September 2021
Antipsychotic drugs that increase prolactin levels have been shown to have a significant association with a heightened risk for breast cancer among women with schizophrenia in a new research. However, one expert states that currently, the clinical implications seem premature.
Data from Finnish nationwide registers on over 30,000 women with schizophrenia was compared. A total of 1069 of these were diagnosed with breast cancer. Long-term exposure to the prolactin-increasing antipsychotic agents was tied to a 56% increase in the risk of developing breast cancer compared to short-term exposure. There appeared to be no significant association with cumulative exposure to prolactin-sparing antipsychotic drugs. The findings are published in The Lancet… (Medscape)
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}